State of Wisconsin Investment Board’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

State of Wisconsin Investment Board’s Portfolio SIOX Stock Details SIOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-2,500	Closed	-$27K	–	1516
2018 Q1	$27K	Hold	2,500	–	–	﹤0.01%	1453
2017 Q4	$105K	Hold	2,500	–	–	﹤0.01%	1422
2017 Q3	$138K	Hold	2,500	–	–	﹤0.01%	1423
2017 Q2	$464K	Buy	+2,500	New	+$438K	﹤0.01%	1300

Other funds holding SIOX

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State of Wisconsin Investment Board's SIOX Position: Q2 2018 in Review

State of Wisconsin Investment Board sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q2 2018, closing a stake of 2,500 shares — an estimated $27K sold.

State of Wisconsin Investment Board first reported a position in SIOX in Q2 2017 and held it in 4 quarters. The position peaked at $464K in Q2 2017. 71 funds tracked by Wall St. Rank hold SIOX as of Q2 2018.

State of Wisconsin Investment Board reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
State of Wisconsin Investment Board sold 2,500 Sio Gene Therapies Inc. Common Stock shares in Q2 2018, an estimated $27K.
State of Wisconsin Investment Board first reported a position in Sio Gene Therapies Inc. Common Stock in Q2 2017 and held it in 4 quarters.
State of Wisconsin Investment Board's Sio Gene Therapies Inc. Common Stock position peaked at $464K in Q2 2017.
71 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q2 2018.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2018, filed 3 Aug 2018.